Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases

The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said pept...

Full description

Saved in:
Bibliographic Details
Main Authors LOPEZ SAURA PEDRO ANTONIO, MARIN PRIDA JAVIER, PENTON ROL GISELLE, RODRIGUEZ JIMENEZ EFRAIN, BESADA PEREZ VLADIMIR ARMANDO, PARDO ANDREU GILBERTO LAZARO, PAVON FUENTES NANCY, PENTON ARIAS EDUARDO, MUSACCHIO LASA ALEXIS, GUILLEN NIETO GERARDO ENRIQUE, LLOPIZ ARZUAGA ALEXEY, GONZALEZ LOPEZ LUIS JAVIER
Format Patent
LanguageChinese
English
Published 19.03.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said peptides and PCB with proteins or other peptides which, owing to the synergistic effect thereof, are suitable for use in the treatment of diseases of the central nervous system involving neurodegenerative and ischemic damage.
Bibliography:Application Number: CN201280032375